Literature DB >> 500188

Evaluation of Pseudomonas aeruginosa toxin A in experimental rat burn wound sepsis.

H L Walker, C G McLeod, S H Leppla, A D Mason.   

Abstract

The search for methods to achieve control of Pseudomonas aeruginosa infection continues with the introduction of aluminum-absorbed toxoid developed from P. aeruginosa exotoxin. This toxoid induces significant titers of neutralizing and precipitating antibodies for toxin A when given with appropriate adjuvants. These experiments show that immunization with aluminum phosphate-absorbed toxoid failed to protect burned rats infected with P. aeruginosa. These and previous experiments show that active immunization with live P. aeruginosa provides good strain-specific protection in the same model. No cross-protection was demonstrated between strains of P. aeruginosa in these experiments.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500188      PMCID: PMC414522          DOI: 10.1128/iai.25.3.828-830.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  SURFACE INFECTION WITH PSEUDOMONAS AERUGINOSA.

Authors:  H L WALKER; A D MASON; G L RAULSTON
Journal:  Ann Surg       Date:  1964-08       Impact factor: 12.969

2.  Experimental studies of the pathogenesis of Pseudomonas aeruginosa infection: evidence for the in-vivo production of a lethal toxin.

Authors:  D D Stieritz; I A Holder
Journal:  J Med Microbiol       Date:  1978-05       Impact factor: 2.472

3.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

4.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

5.  Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa.

Authors:  S H Leppla
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

6.  Adjuvant protection against bacterial infection in granulocytopenic mice.

Authors:  W C Buhles; M Shifrine
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

7.  Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues.

Authors:  C B Saelinger; K Snell; I A Holder
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

8.  Exotoxin production by clinical isolates of pseudomonas aeruginosa.

Authors:  M Pollack; N S Taylor; L T Callahan
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

9.  Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa.

Authors:  K Snell; I A Holder; S A Leppla; C B Saelinger
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

10.  Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo.

Authors:  B H Iglewski; P V Liu; D Kabat
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more
  8 in total

1.  Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa.

Authors:  D E Woods; P A Sokol
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

2.  A Prospective Observational Study Comparing Clinical Sepsis Criteria to Protein Biomarkers Reveals a Role for Vascular Dysfunction in Burn Sepsis.

Authors:  David M Burmeister; Tiffany C Heard; Tony Chao; Karl Alcover; Amanda Wagner; Kevin K Chung; Kevin S Akers
Journal:  Crit Care Explor       Date:  2022-01-05

3.  Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

4.  Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.609

5.  Development of Pseudomonas aeruginosa Biofilms in Partial-Thickness Burn Wounds Using a Sprague-Dawley Rat Model.

Authors:  Kenneth S Brandenburg; Alan J Weaver; Liwu Qian; Tao You; Ping Chen; S L Rajasekhar Karna; Andrea B Fourcaudot; Eliza A Sebastian; Johnathan J Abercrombie; Uzziel Pineda; Jinson Hong; Nathan A Wienandt; Kai P Leung
Journal:  J Burn Care Res       Date:  2019-01-01       Impact factor: 1.845

Review 6.  Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.

Authors:  Maite Sainz-Mejías; Irene Jurado-Martín; Siobhán McClean
Journal:  Cells       Date:  2020-12-05       Impact factor: 6.600

7.  Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.

Authors:  O R Pavlovskis; D C Edman; S H Leppla; B Wretlind; L R Lewis; K E Martin
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.609

8.  Age-related susceptibility of mice to ocular challenge with Pseudomonas aeruginosa exotoxin A.

Authors:  R S Berk; B H Iglewski; L D Hazlett
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.609

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.